Brief: Meridian Bioscience Reports Q4 results
22/11/2022 13:06
Nov 22 (Reuters) - Meridian Bioscience Inc VIVO.O :
* MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR
FISCAL
2022 OPERATING RESULTS
* MERIDIAN BIOSCIENCE INC Q4 REVENUE ROSE 5 PERCENT TO
$333.0
MILLION
* MERIDIAN BIOSCIENCE INC - QTRLY DILUTED EPS OF $0.13
* MERIDIAN BIOSCIENCE INC - QTRLY ADJUSTED DILUTED EPS OF
$0.20
Source text for Eikon: ID:nPn5NHxska
Further company coverage: VIVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VivoPower
See all newsBrief: Vivopower Signs Definitive Heads Of Agreement With Open Innovation Ai To Develop Secure Sovereign Ai Data Centers Across The Nordics, Mainland Europe, The GCC And Selective Countries In Asia
Brief: Vivopower Approves Independent Listing Of 2.2Gw Non-Nordic Ai Infrastructure Platform, Transferring Capital Expenditure Requirements Whilst Retaining De Facto Control
Brief: Vivopower Secures Us$50 Million Pipe At Us$7.50 Conversion Price Per Share
Brief: Vivopower Shortlists Ai Tenants For 41.5Mw Norway Ai Data Center After Receiving Multiple Bids
Brief: Vivopower PLC Prequalifies 30 MW From Mo I Rana Data Center Into Statnett Reserve Markets